Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.95B | $2.70B | $1.80B | $1.43B | $1.17B | $955.4M | $754.0M |
| Operating expenses | $3.93B | $2.81B | $1.95B | $1.56B | $1.35B | $964.5M | $786.4M |
| Operating income | $14.8M | −$101.6M | −$127.8M | −$128.6M | −$178.1M | −$5.3M | −$29.5M |
| Operating margin | 0.37% | −3.76% | −7.10% | −8.99% | −15.26% | −0.55% | −3.91% |
| EBITDA | $45.2M | −$74.7M | −$106.4M | −$111.4M | −$162.3M | $9.8M | −$14.6M |
| EBITDA margin | 1.14% | −2.76% | −5.91% | −7.78% | −13.90% | 1.03% | −1.93% |
| Net income | −$724,000 | −$128.0M | −$148.0M | −$149.5M | −$195.3M | −$22.9M | −$44.7M |
| Net profit margin | −0.02% | −4.74% | −8.22% | −10.45% | −16.73% | −2.40% | −5.93% |
| Basic EPSper basic share | $0.00 | -$0.67 | -$0.79 | -$0.83 | -$1.14 | -$0.15 | -$0.33 |
| Diluted EPSper diluted share | $0.00 | -$0.67 | -$0.79 | -$0.83 | -$1.14 | -$0.15 | -$0.33 |
Reported shareholders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 9.34%19.34M shares |
WELLINGTON MANAGEMENT GROUP LLP | 9.06%18.78M shares |
FMR LLC | 6.72%13.92M shares |
GENERAL ATLANTIC GENPAR, L.P. / GAP Coinvestments CDA, L.P. / GAPCO GMBH & CO KG / General Atlantic (SPV) GP, LLC / GAPCO MANAGEMENT GMBH / General Atlantic Partners 95, L.P. / GENERAL ATLANTIC, L.P. / GAP COINVESTMENTS III, LLC / GAP COINVESTMENTS IV, LLC / GAP Coinvestments V, LLC | ≈6.50%13.48M shares |
General Atlantic (ALN HLTH), L.P. | ≈6.50%13.48M shares |
T. Rowe Price Investment Management, Inc. | 6.33%13.12M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 5.63%11.67M shares |
Invesco Ltd. | 5.00%10.37M shares |
BANK OF AMERICA CORP /DE/ | 4.51%9.35M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.93%8.14M shares |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.75%7.76M shares |
STATE STREET CORP | 3.52%7.3M shares |
Hood River Capital Management LLC | 2.99%6.18M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 2.38%4.94M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.34%4.85M shares |
Capital Research Global Investors | 2.12%4.4M shares |
GOLDMAN SACHS GROUP INC | 1.94%4.01M shares |
Capital World Investors | 1.89%3.91M shares |
Danica Pension, Livsforsikringsaktieselskab | 1.78%3.69M shares |
Bank of New York Mellon Corp | 1.77%3.66M shares |
Percentages use 207.18M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 · 10b5-1 | KONOWIECKI JOSEPH SEVP, Corporate Affairs | SellCommon Stock | 25.0K | $23.00 | $575.0K | 1.13M |
| Jun 18, 2026Form 4 · 10b5-1 | KONOWIECKI JOSEPH SEVP, Corporate Affairs | SellCommon Stock | 25.0K | $22.00 | $550.0K | 1.15M |
| Jun 15, 2026Form 4 · 10b5-1 | Maroney Dawn ChristinePresident | SellCommon Stock | 30.0K | $19.55 | $586.5K | 947.3K |
| Jun 12, 2026Form 4 · 10b5-1 | Kim HyongChief Medical Officer | SellCommon Stock | 36.0K | $19.86 | $714.0K | 331.8K |
| Jun 11, 2026Form 4 · 10b5-1 | KONOWIECKI JOSEPH SEVP, Corporate Affairs | SellCommon Stock | 25.0K | $21.00 | $525.0K | 1.18M |